Our office will be closed Thursday, November 24th (all day) in observance of Thanksgiving Day. We will reopen on Friday, November 25th, at 8:30 am.
University at Sea®
5700 4th St. N.
St Petersburg, 
Office Hours
Monday - Friday
9:00 am - 5:00 pm EST

Cruise Conference Planning For Your Association

Diabetes, Lipidology, Pulmonary Medicine, and
Critical Care

Royal Caribbean's <em>Freedom of the Seas</em>
Royal Caribbean's Freedom of the Seas
7-Night Southern Caribbean Cruise Conference
Round-trip San Juan, Puerto Rico

August 25 - September 01, 2019
14.0 AMA PRA Category 1 Credits™
14 ACPE Credits
14 (part II) MOC points in medical knowledge in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program
13 Hours of Pharmacology for NPs
14.0 Contact Hours

Course Fees:

$895 for Physicians, Attorneys, Psychologists, Doctors of Pharmacy, & Dentists
$695 for Physician Assistants
$695 for Nurse Practitioners
$495 for Nurses, Residents, Students & Others

IMPORTANT NOTE: All conferees, their families, and guests must book their cruise within the University at Sea® meeting group through University at Sea® at 800-926-3775 or by registering online. This ensures our company can provide conference services and complimentary social amenities to all meeting participants and their guests. Thank you for your cooperation.

Tara Dall, MD, FNLA

Tara Dall, MD, FNLA
Dr. Tara Dall is a board certified lipidologist with roots in family medicine and training at the University of Wisconsin Madison. She has spent the last 15 years using advanced biomarker testing in the clinical care of patients. She graduated in the inaugural class of Diplomates of the American Board of Clinical Lipidology in 2005. Her center achieved national recognition as the first fully certified Level II lipid clinic in the United States.

In 2008, Dr. Dall formed the Early Detection Center for heart disease and diabetes near Madison, Wisconsin and served as a clinical associate professor for the Medical College of Wisconsin. Two years later, she brought her fight against heart disease to the web, co-founding Lecturepad.org and FHITtv.org, web platforms that advance clinical understanding and application of advanced lipid and biomarker testing. 

For 3 years Dr. Dall served as Chief Medical Officer of Health Diagnostic Laboratory. As an author and educator on biomarker research focused on the role that insulin resistance plays in diabetes prevention she has expanded the education of physicians to prevent chronic disease. She has a special interest in insulin resistance's role in cardiovascular disease, women's heart disease, Autoimmune disease, polycystic ovarian syndrome, and obesity. She also serves as chief of cardiometabolic education at the non-profit Foundation for Health Improvement and Technology (FHIT).

Known for her passionate delivery of complex medical topics in patient-friendly terms, Dr. Dall is a sought after speaker, traveling the world to present research on advanced biomarkers. She is a also a regular go-to for reporters, appearing on Bloomberg News, CBS Sports, CNN Radio, Reach MD Satellite Radio, and RadioHealth Journal. She was also a regular guest on KTXD-TV's The Broadcast in Dallas, as well as programs on wabcradio.com (Optimal wellness and Forever Young). She continues to practice medicine as a physician founder of AvanceMD Concierge in Richmond, VA which incorporates cutting edge web based technology to the human touch of medicine, providing services to local as well as national and international clients.

Stephen R. Clum, MD, PhD

Stephen R. Clum, MD, PhD
Assistant Professor 
Department of Internal Medicine
Division: Pulmonary, Critical Care, Sleep Medicine
University of South Florida
Tampa, FL

Our staff can assist you with all your travel arrangements.

Target Audience
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists
Program Purpose / Objectives
  • Review new classes of medications for diabetes treatment with impact on CV outcomes, review 2017, 2018 CV outcomes data for GLP 1 agonists, SGTI, and summarize other CV data for older diabetes medications.
  • Evaluate role of biomarkers such as Apo B and LDL P in cardiovascular risk assessment for primary and secondary prevention as well as management.
  • Review impact of biomarkers such as lipoprotein (a), homocystine and inflammation markers on cardiovascular disease treatment.
  • Discuss impact of epidemic of obesity and treatment approach to work up and management of patients impacted by obesity and its comorbities.
  1. New Diabetes Medications that Improve Cardiovascular Outcomes
    • Review cardiovascular outcomes data for currently available diabetes medications including review of new classes of agents, GLP-1 agonists, SGT2 inhibitors, QR bromocriptine
  2. Obesity from the Perspective of a Lipidologist: Root Cause Analysis
    • Identify medical factors, medications, insulin resistance as secondary causes of obesity and how to work up, address and treat these conditions
    • Discuss how diet, genomics, microbiome and environmental factors influence the treatment of obese patients.
  3. Lipoprotein (a), Homocysteine, Hypercoagulation and CV risk
    • Review lp (a), homocystine, MTHFR as risk factors for cardiovascular disease.
    • Discuss how to interpret and treat these biomarkers.
  4. Heart Disease in Women: Putting Prevention into Practice
    • Review cardiometabolic risk in women, use of advanced biomarkers and clinical application.
  5. Complex lipid management: case study review
    • Develop practical approach to using advanced lipid testing as well as treatment approach to reduce residual risks in patients with high risk for events.
  6. Biomarkers: Role of Apo B, LDL-P vs LDL -C in primary and secondary prevention cardiovascular disease, also inflammation
    • Review outcomes data for Apo B LDL P and cost effective approach to treatment using advanced testing.
    • Learn concept of discordance of LDL C vs LDL P or ApoB
  7. Tools for Pulmonary Evaluation
    • Gain understanding of the American Thoracic Society guidelines for pulmonary function testing and
    • Analyze date from cardiopulmonary stress testing and apply this data in the evaluation of patients with unexplained dyspnea.
    • Review criteria for oxygen qualification. Understand the guideline recommendations for patient evaluation and use of oxygen during air travel.
  8. COPD: Medical and Non-medial treatments.
    • Utilize the most recent GOLD guidelines to direct medical therapy.
    • Identify COPD patients that may benefit from surgical and non-surgical lung volume reduction.
    • Review the role of NIV in both the acute and stable COPD patient.
  9. Treatment of Uncontrolled Asthma
    • Understand expert consensus recommendations for accessing asthma control.
    • Apply these expert consensus recommendations to the management of asthma patients.
    • Review data on several recently FDA approved medial treatments for asthma and FDA approved bronchoscopic interventions for asthma treatment .
  10. Interstitial Lung Disease: IPF and Sarcoid
    • Recognize the broad differential diagnosis of diffuse parenchymal lung disease.
    • Understand the ATS/ERS diagnostic criteria for IPF.
    • Understand the various clinical measures predictive of IPF survival and how they are affected by two recent FDA approved medications.
    • Recognize the clinical presentation of pulmonary sarcoid.
    • Formulate a treatment plan for pulmonary and cardiac sarcoid.
  11. Pulmonary Nodule Guidelines and Lung Cancer Screening.
    • Describe characteristics of pulmonary nodules that influence clinical suspicion for benign or malignant character.
    • Apply recommended guidelines for following sold, ground glass, and part solid pulmonary nodules.
    • Understand the key elements of lung cancer screening and identify patients who are candidates for screening.
  12. Acute Respiratory Distress Syndrome: Clinical update 2019.
    • Define ARDS using Belin criteria.
    • Apply non-invasive ventilation in the management of ARDS.
    • Understand current recommendations for mechanical ventilation in patients with ARDS.
    • Apply salvage strategies such as prone positioning, ECMO, paralytics, and vasodilators in refractory ARDS.
  13. Pulmonary Embolism: Treating patients based on risk stratification: a review of the literature and evidence-based guidelines.
    • Understand the risk stratification used for acute PE.
    • Apply radiological imaging, laboratory markers in risk stratification of PE
    • Understand treatment outcomes of high and intermediate risk patients with PE treated with thrombolysis vs standard anticoagulation.
    • Apply current ACCP recommendations for duration of treatment of acute PE.
Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.
Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.

Cruise Itinerary

Sun Aug 25 San Juan, Puerto Rico
- 8:30 pm
Mon Aug 26 *At Sea - Cruising
- -
Tue Aug 27 Oranjestad, Aruba
8:00 am 9:00 pm
Wed Aug 28 Willemstad, Curacao
8:00 am 8:00 pm
Thu Aug 29 Kralendijk (Bonaire), Antilles
8:00 am 5:00 pm
Fri Aug 30 *At Sea - Cruising
- -
Sat Aug 31 Philipsburg, St. Maarten
8:00 am 5:00 pm
Sun Sep 01 San Juan, Puerto Rico
6:00 am -
*Tentative course schedule, actual class times may differ.
Royal Caribbean Freedom of the Seas Map

Ports of Call

San Juan, Puerto Rico - In days of yore, the waters near Puerto Rico teemed with pirate ships commanded by the likes of Sir Francis Drake. Aye, they are long gone, but in their wake they have left an island of national treasures: La Casa Blanca, built in 1501 for the island's first governor, Ponce de Leon; the cobblestone streets of Old San Juan; the tropical rain forests of El Yunque.

At Sea - Cruising - Cruising

Oranjestad, Aruba - A Dutch jewel with a tropical touch. In Oranjestad, Aruba's capital, explore the colorful floating market and Nassaustraat, brimming with quaint shops. Head for the beach where water sports abound: snorkeling, rides on glass bottom boats and submarines. Or venture into the countryside to see the haunts of the huge green parakeet, the unique rock gardens of Casi Bari, the curious divi divi tree, forever bending in the tradewind breezes

Willemstad, Curacao - An isle of Dutch treats: gabled storybook houses, duty-free Delftware, the famous Curacao orange flavored liqueur

Kralendijk (Bonaire), Antilles - Kralendijk is the sleepy capital of Bonaire, an island in the Dutch Antilles. Kralendijk is lined with delightfully pastel stucco houses, in pinks, oranges and lime greens. Famous for its diving - the island is surrounded by a Marine Park - Bonaire also offers such treats as flamingos, hiking and the only barefoot casino in the Caribbean.

Philipsburg, St. Maarten - An island under two flags. Sample the Dutch treats of Philipsburg: chocolate, cheese, delftware. On the French side linger over bouillabaisse, shop for Parisian perfumes.

Our staff can assist you with all your travel arrangements.

Questions? Call us at 800-422-0711.
We can assist you with all your travel arrangements. We'd be happy to help you plan your flights, hotels or tours before and/or after your cruise conference.
Please note that our shore excursions are operated separately and
independently of those offered by the cruise line.
©2019 - University at Sea®